PAR DRUGS & CHEMICALS
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Par Drugs & Chemicals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.35₹ 2.47
As on Dec 24, 2025, 3:47 PM IST
Par Drugs & Chemicals Price Performance
Today's LowToday's High
₹103.26₹108.40
₹107.47
52 Weeks' Low52 Weeks' High
₹81.01₹220.00
₹107.47
Open Price
₹106.25
Prev. Close
₹105.00
Volume
31,737
Over the last 5 years, the share price of Par Drugs & Chemicals has gained 25.57% CAGR. Over the past year, the corresponding return has been -47.68%.
Par Drugs & Chemicals’s current P/E of 13.65x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Par Drugs & Chemicals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Par Drugs & Chemicals | 8.41 | 17.33 | -3.14 | 10.24 | -47.68 | -10.26 | 25.57 |
| Sun Pharmaceutical Industries | -3.12 | -2.46 | 6.75 | 4.53 | -4.51 | 20.21 | 24.09 |
| Divi's Laboratories | 3.23 | 2.16 | 8.56 | -1.05 | 12.35 | 23.74 | 11.62 |
| Torrent Pharmaceuticals | 1.68 | 3.12 | 6.08 | 20.54 | 12.79 | 34.68 | 22.45 |
| Cipla | -0.04 | -0.51 | -2.71 | -0.41 | 1.39 | 10.92 | 12.42 |
| Dr. Reddy's Laboratories | -0.49 | 3.23 | -2.49 | -5.35 | -6.30 | 14.21 | 4.00 |
| Lupin | -0.29 | 5.37 | 5.83 | 9.13 | -2.88 | 41.59 | 16.63 |
| Zydus Lifesciences | -0.03 | -0.96 | -11.41 | -4.85 | -4.87 | 29.69 | 13.40 |
| Mankind Pharma | 3.89 | -1.32 | -13.30 | -4.95 | -24.64 | 15.53 | 9.05 |
| Aurobindo Pharma | 1.54 | 1.46 | 11.05 | 9.71 | -4.04 | 40.45 | 5.91 |
| Alkem Laboratories | -1.11 | -1.05 | -0.18 | 15.69 | 2.95 | 21.79 | 13.80 |
| Abbott India | 3.20 | -3.91 | -5.56 | -9.58 | 0.01 | 9.41 | 12.64 |
| Laurus Labs | 7.41 | 10.74 | 19.24 | 62.02 | 91.27 | 41.64 | 25.51 |
| Glenmark Pharmaceuticals | 3.68 | 9.65 | 0.07 | 20.02 | 31.53 | 68.13 | 32.42 |
| Biocon | 3.17 | 0.78 | 10.98 | 14.08 | 15.63 | 14.52 | -3.74 |
| GlaxoSmithKline Pharmaceuticals | -3.71 | 0.40 | -9.45 | -22.98 | 9.82 | 23.17 | 10.17 |
| Anthem Biosciences | 0.47 | 5.73 | -18.62 | -8.55 | -8.55 | -2.94 | -1.77 |
| Ipca Laboratories | 1.39 | -0.95 | 4.92 | 6.02 | -10.56 | 18.59 | 5.51 |
| Ajanta Pharma | 5.16 | 8.72 | 8.03 | 6.64 | -2.47 | 32.09 | 19.66 |
| J B Chemicals & Pharmaceuticals | 1.07 | 3.35 | 7.07 | 0.91 | -2.24 | 23.06 | 28.61 |
Over the last one year, Par Drugs & Chemicals has declined 47.68% compared to peers like Sun Pharmaceutical Industries (-4.51%), Divi's Laboratories (12.35%), Torrent Pharmaceuticals (12.79%). From a 5 year perspective, Par Drugs & Chemicals has outperformed peers relative to Sun Pharmaceutical Industries (24.09%) and Divi's Laboratories (11.62%).
Par Drugs & Chemicals Financials
Par Drugs & Chemicals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 104.32 | 104.77 |
| 10 | 99.96 | 102.07 |
| 20 | 95.58 | 99.14 |
| 50 | 97.56 | 98.49 |
| 100 | 100.63 | 101.27 |
| 200 | 99.95 | 115.65 |
Par Drugs & Chemicals Share Holding Pattern
In the latest quarter, Par Drugs & Chemicals remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 26.63% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Par Drugs & Chemicals Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Par Drugs & Chemicals fact sheet for more information
About Par Drugs & Chemicals
Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 100.97 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address815, Nilamber Triumph, Vadodra Gujarat 390007
- Contact
Management
- Mr. Falgun Vallabhbhai SavaniChairman & Managing Director
- Mr. Jignesh Vallabhbhai SavaniExecutive Director & CEO
- Mr. Pravin Manjibhai BhayaniIndependent Director
- Mrs. Kajal Chintanbhai VaghaniIndependent Director
- Mrs. Krishna Mitulbhai ShahIndependent Director
- Mrs. Bintal Bhaveshkumar ShahIndependent Director
FAQs on Par Drugs & Chemicals Share Price
What is the share price of Par Drugs & Chemicals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Par Drugs & Chemicals is ₹107.47 as on Dec 24, 2025.
What kind of stock is Par Drugs & Chemicals?
The Par Drugs & Chemicals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Par Drugs & Chemicals?
The market cap of Par Drugs & Chemicals is ₹132.24 Cr as on Dec 24, 2025.
What are today's High and Low prices of Par Drugs & Chemicals?
Today’s highest and lowest price of Par Drugs & Chemicals are ₹108.40 and ₹103.26.
What are the 52 Week High and 52 Week Low of Par Drugs & Chemicals?
The 52-week high/low is the highest and lowest price at which Par Drugs & Chemicals stock has traded in the past 52-week or nearly a year. The 52-week high of Par Drugs & Chemicals is ₹220.00 and 52-week low of Par Drugs & Chemicals is ₹81.01 as on Dec 24, 2025.
How has the Par Drugs & Chemicals performed historically in terms of returns?
The Par Drugs & Chemicals has shown returns of 2.35% over the past day, 17.33% for the past month, -3.14% over 3 months, -47.68% over 1 year, -10.26% across 3 years, and 25.57% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Par Drugs & Chemicals?
P/E ratio of and PB ratio of Par Drugs & Chemicals are 13.65 and 1.24 on Dec 24, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse